can glp-1 cause depression The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy The interface of depression and
Description
doi:10.1038/s41586-019-1902-z Pfizer

95% CI, 0.96-3.85, respectively)

However, the pipeline of oral and multi-agonist assets from Amgen, Viking Therapeutics, Structure Therapeutics, and others is expanding rapidly

F., Ciudin, A., Yokote, K., Halpern, B., Shukla, A

Thus, DPP4 inhibition might have pleiotropic effects in adipose tissue
Staying informed and maintaining open communication with your healthcare team can help you make choices that support your health and hemophilia management
